MedPath

Telephone-Delivered Interventions for Smoking Cessation

Not Applicable
Completed
Conditions
Smoking
Registration Number
NCT02421991
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

The purpose of this study is to demonstrate that Acceptance and Commitment Therapy's (ACT) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1275
Inclusion Criteria
  1. ages 18 and older
  2. smokes at least ten cigarettes per day (to be eligible for NRT) and has done so for at least the past 12 months
  3. wants to quit smoking in the next 30 days
  4. if concurrently using any other nicotine or tobacco products wants to quit using them within the next 30 days
  5. willing to be randomly assigned to either group
  6. willing and able to speak and read in English
  7. willing and medically eligible to use NRT
  8. resides in the U.S., and expects to continue for at least 12 months
  9. not participating in other smoking cessation interventions (including our own intervention trials)
  10. has regular access to a telephone.
Exclusion Criteria

The exclusion criteria are opposite of the inclusion criteria listed above.

In addition we will exclude:

  1. anyone who is pregnant or breast feeding
  2. has had a heart attack in the past 30 days
  3. has unstable angina
  4. has evidence of arrhythmia in the past 6 months
  5. has a history of severe skin reaction to adhesive patches.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
30 day point prevalence abstinence12 months

No smoking in the past 30 days, as reported at 12 month post treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Fred Hutchinson Cancer Research Center
πŸ‡ΊπŸ‡ΈSeattle, Washington, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.